点击次数：

论文类型：期刊论文

发表时间：2018-01-01

发表刊物：EUROPEAN JOURNAL OF INTEGRATIVE MEDICINE

收录刊物：SCIE

卷号：17

页面范围：1-8

ISSN号：1876-3820

关键字：Camellia euphlebia; Fatty liver; Steatosis; Lipid accumulation; Triglycerides; HepG2 cell; NAFLD

摘要：Introduction: Camellia euphlebia is a medicinal and edible plant used to treat hepatic disease in Southern China. However, there have been no reports on the anti-obesity and hypolipidemic effects of Camellia euphlebia flower. This study evaluated the hepatic lipid-lowering potential of different preparations of Camellia euphlebia flower extracts using in vitro models.
   Methods: A model of hepatic steatosis in the HepG2 cells was induced by oleic acid. HepG2 cells were divided into control group, oleic acid group, oleic acid plus aqueous extract group and oleic acid plus ethanol extract group. The cytotoxicity was quantitatively assessed by methyl-thiazolyl-tetrazolium and lactate dehydrogenase release assay. Lipid accumulation and intracellular triglyceride level were also evaluated by oil red O staining and a commercially available assay kit respectively. Expressions of 3-hydroxy-3-methylglutaryl CoA reductase, fatty acid synthase, acetyl-CoA carboxylase and glycerol-3-phosphate acyl transferase genes in the HepG2 cells were examined by reverse transcription polymerase chain reaction.
   Results: Treatment of HepG2 cells with 100 mu g/ mL aqueous or ethanol extract significantly reduced lipid accumulation and the level of triglyceride in the cells. Furthermore, pre-treatment of HepG2 cells with 100 mu g/ mL aqueous extract effectively down-regulated the mRNA levels of fatty acid synthase, 3-hydroxy-3-methylglutaryl CoA reductase and glycerol-3-phosphate acyl transferase, whereas 150 mu g/ mL ethanol extract only down-regulated the mRNA level of 3-hydroxy-3-methylglutaryl CoA reductase.
   Conclusion: These results provided support for the potential preventive effect of Camellia euphlebia flower on nonalcoholic fatty liver disease and could partly explain the basis of using Camellia euphlebia for the treatment of fatty liver.